症例報告 - 浜松医療センター
Contents
1.2. 2 8 H TEM S Ira Special articles 4 1 2010 22 2 22 H 28 H Stephen H Schultz MD Residency Program Director Department of Family Medicine University of Rochester School of Medicine amp Dentistry Associate
3. 2 KRKE
4. Tes 1 18 20 HbA1c
5. 10
6. hepatic peribiliary cysts 1 X 1 Nakanuma Y Kurumaya H Ohta G Multiple cysts in the hepatic hilum and their pathogenesis A suggestion of periductal gland origin Virchows Arch A pathol Anat Histopathol 1984 404 341 350 2 BIK Ze X Je UF peribiliary cysts 1 H Ei 2005 66 1161 1169 3 Hepatic peribiliary cysts 4
7. BAAS 7
8. 211 2010 6 12 X 1 Guidelines for Diagnosis and Treatment of Pa tients with Vasospastic Angina Coronary Spas tic Angina Circulation Journal Vol 72 Suppl IV 2008 2 Yamagishi M Miyatake K Tamai J Nakatani S Koyama J Nissen SE Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or mini mally narrowed coronary segments J Am Coll Cardiol 1994 23 352 357 Nishihira K Serotonin induces vasoconstriction YN 3 of smooth muscle
9. CERIS CREME EROR ER E VERME 4 1 2010 1 2 CPA
10. Infutest2000 DNI NEVADA 10 6
11. 1 2 4 1 2010 1 vo1 31 No 1 P96 100 2006 1 P182
12. 10 16 MMT 3 4 4 4 ADL
13. 1 2 3 m t 109
14. X 1 4 2008 52 68 2 22 6 2 http www jshp or jp banner hiroba html 140 4 1 2010 Hl
15. 30 3 HbA1c x B 1 3 2007 70 72 2
16. 1 2 mg 3 5 DHA PAM 160 1 2g 20 40mg kg 100ml 15 30 1 0 5mg hr 1
17. ARISE OE LEAD ARE BROTERU GS ITA i x U EO Wa T flue de ARO X VIN OFFER http www hmedc or jp 187 4 1 2010 X AR BB A MN HR TE CS
18. 136 NANDA NANDA 2
19. 2 AAFP American academy of family physicians 6 300 7
20. 100 Dr 11 1
21. gt gt 3 HE ra M 4 HE 153 4 1 2010 pT4pNOpM1 StageIVB
22. Kinyoun Sabouraud BCYE a Nocardia asteroides Mycobacterium intracellulare
23. ZE 30 10 2 100 1 6 2 1
24. geometry 9 5 geometry 11 1 21 4 Non contact map ping
25. 3 Non contact mapping NCM geometry far field potential geometry 1 one beat mapping 5 4 1 2010
26. KOFLOC 1 2 3 5 8L 1 KOFLOC 1 KOFLOC 1L 10L 0 1L 0 1L 0 05L
27. X 1 2010 87 73 77 2 3 i Ensite Mapping System 2009 68 171 173 3 3 2007 27 579 580 4 Ensite system Cardiac Practice 2009 20 234 238 4 1 2010 Gastrointestmal stromal tumor GIST 1 GIST33 2 X8 LIE Bk A BE ES AB me FU
28. ER 1 000 15
29. MRI CT
30. U 7s A
31. 10 Guidelines for Adolescent Preventive services 144
32. 1 DM COC DMG ORKE amp DM EEE DPT PT DM DM DM PT 4131
33. 176 Mvi 1 BAZ 30 2 31
34. 9 4 1 2010 OSBE X 1 Mackay J Eriksen M The Tobacco Atlas Geneva WHO 2002 ep BEBE 2002 3 25
35. SH 5 1 412
36. 1 CPA CPA
37. 4 TQM Total Quality Management
38. Ween pg JU E ee SAUCE WES aE 70 9
39. 1 NANDA 4 1 2010
40. 9 5 voids SEB EXP KB CTO A ARR dg HGS TX Edge UL CHE 2 15 4 1 2010 MEALAED SS CB RJL 3 16 CT
41. 21 1 D 2 3 2 3 1 1 4 HARER 1 20 4 2007 7 2010 3
42. 2007 7 16 10 30 6 8 AGERE 6 15 182 1 807 39 000 1 1 7 20 8 11 25 244 713 117 7 FAX 8 1 125
43. 72 TERUMO STC 525 1 57 TE 331S 2 15 2006 4 2010 3 4 2 Infutest 2000 DNI NEVADA 3 1 TERUMO STC 525 2 TERUMO TE 331S Infutest 2000 Wil 3 4 1 2010 Infutest 2000 5 PAPER 1 000m
44. 211 2010 6 12 X 1 Vol 104 No 5 2009 826 829 2 Angrill J Agusti C Celis R et al Bacterial coloni zation in patients with bronchiectasis microbeological pattern and risk facters Thorax 2002 57 15 19 Mark CP Sharon MH Sally JH et al An Investi gation into Causative Factors in Patients with Bronchiectasis Am J Respir Crit Care Med Vol 162 2000 1277 1284 Laurenzi G Potter RT Kass EH Bacteriologic flora of the lower respiratory tract Lancet 1961 265 1273 1278 Less A McNaught W Bacteriology of lower res 3 s 4 x 5 piratory tract secretions sputum and upper res piratory tract secretions in normals and chronic bronchitis Lancet 1959 i 1112 1115 4 1 2010
45. 2 2
46. 2 2 2 Oat 4 119
47. FOLFIRI mFOLFOX 6 22 4
48. McVay 2 8 DD D Y 7A BO RMN AT eR ES 3 9 CT
49. 21 1 1 1 5 4 FOILPBRENRAM BIA Chere SMT
50. 4 1 2010
51. 3 3 1 4 1 2010 Ax eh FA 1 3 3 2
52. CWA Bo 2009 1
53. ADL PT PT ADL
54. BADIA QOL 2008 6 CDEJ 2007
55. aL 1 ID 2 3 1 3 10 4 5 6
56. 2007 9 2008 11 141 4 1 2010 2008 7 21
57. 4 1 2010 QOL X B 1 SEE 2 DX 1998 pp 5 65 2
58. wl 1 3 1 2006 6 1 1 550
59. interventional radiology SF
60. 2 51 65 4 1 2010 BE X B 1 REIRA DERE SECHE fl 2009 3 1 10 19 2
61. ipn ALO HEIL emet Ci Sieh eh OO uo eam 2009 IT
62. 1991 1 1 2008 3 31 22 9 40 9 2008 4 1 2010 3 31 2 30
63. IM Il Tm WV II V 5 5 5 3 ZI 4 6 6 1 2 2 5 5 3 6 6 1 5 5 1 1 1 1 5 5 1155 1 6 6 2 11111 2 7 7 4 6 6 1111 1 2 12 2 4 1 2010 0 oo 2 RM E tue A a
64. Pa02 63mmHg PaC02 48mmHg cx M t 71 83 96 PT
65. RE Activity of Daily Living FADL ADL Occupational Therapy OT 40 ICU
66. MRI 63 2008 7 X 1 Wendel AV A case of floating gallbladder and kidney complicated by cholelithiasis with perfo ration of the gallbladder Ann Surg 1898 27 199 202 2 Td SEAL be BE 1932 33 719 3 4 5 6 7 8 Va 4 1 2010 1 2005 121 Ikematsu Y Yamanouchi KK Nishiwaki Y et al Gallbladder volvulus experience of six consecu tive cases at an institute J Hepatobiliary Pancreat Surg 2000 7 606 609 Gross RE Congenital anomalies of
67. 5 Tertiary Survey Tertiary Survey M PTD ARLERI 6 15 Up X B 1 JATEC 3 3 2008 2 http www jtcr jatec org index_jatec html JATEC JTCR internet accessed2010 3 24 158
68. 3 MR 9 9 3
69. 1 1998 2009 1 MM 2008 1 000 2009 1005 2009 1 E FURL UCHR MBERE SALET Kis 2 ISR CHiN UCR SIT He BR AVIA BELPER LAT RMS lt 4 oC HP TOWRA TC E CUO oncologic emergency Cm OBA Ere REAR Y interventional radiology 1000 800 600 400 m 200 0 HER ERLE ER ES SR LP DS PPP GP PF oF Fh Sa 1 X1 2009 1005
70. 3 10 10
71. 2 Vie
72. 2002 Angril 59 Nocardia asteroides 1 2 2 3 9 5 Nocardia asteroides colonization ST Aocarg7a asteroides
73. 3 supportive 4 palliative GOL 2
74. 3 2009 11 2010 2 HO 4 138
75. F 34 36Fr 16 28Fr 38 0 5 15 1 200 300ml 10 20ml kg 5 201 TEX 50g 8 1
76. SMCS LEHT KREAS SAKA BHA MRI BHA 2 BHA
77. TELIXUE BAS C d 2i WIREZEESO 3 MSHI RO FEE RT 28 45 5 i AERA I SEH OG 7205 5 DT fT Air Way Scope device B C D B SpO02
78. 3
79. 2
80. 2 1 1 2 4 1 2010 2 2 1 1
81. RI L
82. d 2 2 4 26 21 53 5 24 24 52 6 27 15 58 7 34 9 57 8A 25 12 63 9 21 7 72 102 8 50 47 1 10 HPF
83. Ol 67 1 Trace 2 Poor 0 O Zero 2 7 3 PT
84. 1 MRA MR 1 10 6 10 EDAR HEK 8 10 8 6 8 4 10 8 6 4 ut 4 30 2 2
85. 25 9 CT MRI CT 4 1 2010 MRI CX CHEB PAZ TP 2 Te stent UCHEL amp 5 RADA amp 1 26 AVEO Wala MAT NACL GL EEE OO SAC IM non occlusive mesenteric ischemia NOMI 2
86. 185 4 1 2010 10 lecture records 6000 1 400 5 300 5 10 186 4 1 2010 W R a BAR d NM OX 4
87. 30 1 7 5g 150mg kg N
88. 2 DM PT FES DM PT DM PT DM DEAS 3 C 20 50 LMG c dl DM 4
89. 75 AR 65 S 2009 7 X 2010 2 25 Wk BAYT AGA TIA 2 X CT LVFX 3 2 1 3 10 LFA
90. 2 2 4 1 2010 2 3
91. PV g IPV d 1 9 IPV 1 Intrapulmonary Percussive Ventilator IPV CO 52 60 70 15 43 2 3
92. 90 3 6 2 LCWDENAC POR MAILMAN ZAR EET LOCI ELI CRE
93. OT OT OT X B 1 Vol 42 NO 12 2008 p1322 1324 2 WEED
94. 1 lt
95. 3 2009411 2010 2 4 M 55 432 0 24 58 039 0 30 1 845 1 41 Be prepared to avoid the adverse reaction of drugs 1
96. FCA VE PRUE EB E FEO x Xp PTCH Patched protein homolog 1 2005 WHO WER kO FARK E Tui ESBIBVIO HREATR 4 dU EB L ESR A 32 CEU Seer EPR ENS ex 1478 AVE 2007 10 ALARA 5 0 ENS 2007 9 7 1 s GR g E Se Nee PEs EUS PED See fla 1 X CTET MERR ALO Eai E HER RTIRA RED Te HUD amp Ue Seite ERED ESO AEBS amp HLL TO 2
97. 9 PT ADL
98. R CHOP 2 CdA 2 3 3 99
99. 2007 2008 _ DA Te m r e ate y Bll 1 1 DVD 2
100. 8 X 1 WART EAE 239089 Il 840 847 1975 2 Frer AA friedman ALJarrett WJ Dentigerous cyst involving the maxillary sinus Oral surg 34 378 380 1972 3 1 27 1113 1117 1989 4 Thoma KH Goidman HN Oral Pathology 5Edition 780 829 CV Mosby CO St Luis 1960 5 Forssell K Sorvari T E et al An analysisi of tshe recurrence of odontogenic keratocysts Proc Finn Dent Soc 70 121 134 1974 4 1 2010 1 pi 330 SH RISE 9 2 AY PR 3x FHBHBU AH SREB
101. WL damage control surgery perihepatic glove packing 2 3 23 4 DROES 24 CT lt OBA RRO Hifp OO PAS amp 0 7 LESAN ECS REAM THA CT 5 25
102. 1 hepatic peribiliary cysts 20 07 5 3E3 WE amp MAE TATE 7e d CT
103. Medical Examiner Coro ner 162 Y es di
104. X B 1 P8 Z 2005 2 2008 3 Vol 56 No 14 P69 74 4 1 2010 2004 4 RARR 2000 137 4 1 2010 EE ME AA
105. 3 ADL x B 1 MB Med Reha 2004 41 62 70 2 2007 34 401 WN 2006 33 268 2007 13 35 42 ICU 1993 20 176 179 4 1 2010 Te PU FEO MY ECT AFRO ST SLE ORE
106. 4 1 2010 1 2008 2008 4 1 Ein a 08 10 GERA ee felted al ca FE 2 2009 2008 4 1 09 04 ee w al fi 09 07 I 2008 4 1 2009 3 31 1 5 2 1 1 1 26 CHEST ACK adr 7c Pipe 2009 3 31 E E FREIE HH Filter
107. 9 9 AD 79
108. PCT PCT PCT PCT 1 2 PCT PCT Bo 3
109. 9 X 1 RE WES 6 1999 637 638 2 vol 5no 4 2006 72 76 3 Clinical Science 1998 114 119 4 82 11 2005 1845 1850 154 iil ZS DR Lecture records 4 1 2010
110. D GM Cf AMI vei SERRIESUDAE CSA PCI 25 51 20 BI 560 10 14 A II aVF ST 160cm 65kg BMI 25 4 96 64mmHg 82 min 8 10 WBC 15800 mm3 Hb 14 8 g dl Ht 44 0 Plt 22 2x10 mm3 AST 25 IU L LDH 176 IU L CPK 97 IU L CPK MB 6 IU L Troponin T HDL C 25 mg dl LDL C 90 mg dl TG 109 mg dl BS 183 mg dl HbAlc 5 2 DL ILaVE V6 COST V1 5 JaVLaVR ST 1
111. OT ADL OT OT 4 1 2010
112. 6 6 6 10 6 7 10 HE 67
113. 80 6 22 23 Bo MA medical assistant 12 NP nurse practitioner
114. ADL ADL PT 65
115. 2 Airway Breathing Circulation Dysfunction of central nervous system Environmental control flo TER ABCDE 1 load amp go 1 Mechanism of injury Injury site Signs Treatment
116. 7 27 3 XP CT CT 1 CT CT 19 31 4 free air CT air window free air 32 32 freeair CT
117. W 50 m m mU MAS RM ROM AA dS m Wie E80 MLA ADDS amp Rl Ae ERC do S 72 60
118. GIST GIST imatinib GIST imatinib GIST GIST GIST imatinib 1 GIST 33
119. MRI WH CE FARE OFEBUE UG gt o MEt 55
120. 1 X B 1 2005 1 3 hil 128 4 1 2010 ME ME BE tE BA pU Ral RW 2 DM DM PT DM PT DM
121. Ver 6 x B 1 2 IRA P38 P48 2005 6 142 4 1 2010 B H21 2 AH
122. g R CHOP 1 R CHOP 2 CdA cladribine amp 63 X 200X XX 4
123. 2 2 ABIL proton pump inhibitor PPI H2 blocker CHS OM ABC KARL COPMABR CHS 3 3
124. CRT Capillary refill time 1 2 PS FAST Focused Assessment with Sonography for Trauma FAST Ws Morisonf amp Jp JEDE Wa es OO VILE nd CT
125. 21 3 U SCANNER Il U SCANNER I US3100R USliner 1 d Usl iner A U Scanne r I B US3100R 6 7 PC TEETE iib Ligeia 1 3 du Er PER FaN wei SOUM TIE TTE Py au man an Bt DEM LL CT ou K Sw gno m AE erie uvm ien US NE ie Ser ta NT i 3B ur e E z eas ro rsjrejr jroj re rio ri jri2 esc Wy agp Fo Ea ke en xan enam anan mum mauk kear smk muc 2 PC 2
126. ON A d ui M PT PT PT PT OF i 1 55 BI TV ADL PT 1
127. 126 FR pi hey i J gt 2 P Lic je dre ATR rc 5 PT X535 od lt goo gage Q Rr az XE al lt A 3165 3 4 eie eho ems eG 5 3 24 4
128. MERRIE 9 75 1 DERE LI WESS EUER ELCHE OD CK e d 145 cm 33 kg BMI 15 6 kg m2 36 6 ch E WBC 7900 21 CRP 0 13 mg dl FHA Zi SS RE OO IL amp PF D HA SEEK amp FAA DO AT RE amp e NETS Ka 1 1
129. A OO RIHI U 2x 23 5 ADL 4 1 2010 PT QOL 9 PT PT PT
130. ADL QOL ADL ADL 42 H17 4 H19 7 H20 4 4 6 Hy ct ADL PT X 1A
131. Cancer Board Eves IIB
132. 79 2002 GM CSF 60 GM CSF 211 2010 X 1 57 1147 1154 2009 2 99 279 286 2007 3 BHRI VRARE 2 1 476 479 4 Edward D Chan et al Diagnosis and treatment of pulmonary alveolar protenosis in adults in Up To Date 2010 5 47 3 2009 185 1
133. 156 CT 2 1 A D B ZE CLE 1 ABCDE ABCDE Primary Survey 1 Secondary Survey 3 Primary Survey PS 10 15 A
134. Pusher pusher 1 ADL pusher ADL pusher X 1 Pusher pusher ADL 77 1 20 8 3
135. A Assessment P Plan ite REBAR Le
136. Ai Autopsy imaging Ai lt CPA Ai PMi Post Mortality imaging CPA CT CT 1 1 60 CPA CT 1
137. CT 1 1 CT FLIPI Follicular Lymphoma International Prognostic Index 5 63 1V 4 LDH 4 high risk R CHOP rituximab 375mg mz day1 cy clophosphamide 750mg m day2 doxorubicin 50mg m day2 vincristine 1 4mg m day2 predonisolone 60mg mz day2 6 6 2
138. 114 CT ECG mA Modulation 80 5 Modulation x B 1 HERE CT 2006 62 804 810 ECG Dose Modu lation k 2006 62 2 5 3 VC VCT select
139. CT MRCP hepatic peribiliary cysts hepatic peribiliary cysts Hl hepatic peribiliary cysts hepatic peribiliary cysts HS hepatic peribiliary cysts
140. 3 4 3 21 2 1 1 2 2 3 1 5S 3 55S 2 5S 4 5S 3 R D 5 S 23 1 D 3 1 MRAR 1 1 4 15 00 16 00 2 4
141. BE DOA 159 4 1 2010 CO Hb
142. 5B Ach II aVF ST Nitro glycerin u ARIKE Ono 5C 7 dh l f ENS py V 5A 5B Ach 5C Nitroglycerin 20 je ERO ERA E UC ERS MF OW BRR AE BEE NO NO IVUS i set E U 7 OR 3E 238815 5 11 5 2 Ere AACA eK E
143. pipe eir E deu 10 2 Dr 3 ee pe A 2 3 M E A 0
144. 22 9 1 2 BEL Te IN OUT
145. Bi 21 8 23 mp X 1 Morris JC and Holland JF Oncologic emergencies accessed 2010 5 22 http www ncbi nlm gov bookshelf br fcgi book cmed amp part A41500 2 The Washington Manual of Surgery 5th ed Lippincott Williams amp Wilkins 2008 1 685 62009 70 667 672 2009 57 161 165 D 1 2008 70 1226 1229 6 LAS ela mC E
146. 10 1 18 18
147. PCT PCT PCT PCT 99 395 494 2 2009 9 14 9 30 3
148. 2 6 10 6 8 12 14 8 MORE 8 10 6 6 MEMEA 6 30 HAE M 7 4 1 2010 IK SUK IK AES
149. 4 1 2010 CT hepa Ula 2 2 CT PI EOS o fit ilH s L ser TUR 2 3 5 MRI MRI MRCP 3 3 MRI MRCP RI
150. OT DVD OT JAM 28 MMT 17 3 1 4 2 4 1 2010
151. We ES ZE 23 EMOR Z HAL LESS Bu Hie BUCKY ENLA 5202 ONE fni S Clk Golden ORE TIIRI Frer DRETI _E SAMAR REIS DURES ESR OER PAIZO CT Thoma Dt U7 ESA pa t_E SAD RE U ERDIAK KO Ae Ee EAH LEW 7 60 O PIROT AORA a EER
152. 2 5 BAIT 4 1 UE
153. 18 18 6 JIS 2 800mmHg
154. 3 1 2 4 21 4 2 134 1 2
155. 2 CdA 6 12 2 CdA 20 6 4 2 6 QA HGP AEE LO BEA g dl mE 0 30 60 90 120 150 180 6 4 1 2010 R CHOP
156. 2006 29 32 3 149 4 1 2010 2008 40 41 190 194 CPC 4 1 2010 Stage IV 57 2009 AR SG CPCB ft H M HA 57 XE dk 19 Ope B C T4N0M1 Stage IV EL 2078 SH C 2008 4 8
157. ADL PT 82 18 3 19 4 11 3 20 5 5 6 1 2 ADL
158. 9 BREED PEPE DEI T 5 PCI PCI 7 9 PCI fi CED D DNA ZLEE BIC AZFV b T6 GR IK ea FEAR TI EAT hB TRECE AT Y bE PCI 9 CAG 4 1 2010 PCI
159. 6 10 4 10
160. 7 TD 8 1 9 St 13 3 29 10 11 19 6 1 182 4 1 2010 1 Review article 300 ZAA
161. Be OVEN HK 4 1 2010 4 ce Ue fae 3 Nea PERE EES 20054F WHO 0 FREE 1 PTCH 2 3 4 5 Forssell 59 70 X 40mm
162. 2009 7 6 9 50 1 25 173cm 61 1kg gt 2 300g 26 17X11cm 18X 8 cm KERA WEMLO IE ERR MERKS f gt 740g 670g 1 5cm 4 cm 4 1 2010 gt 1 430g 3 4 gt
163. 53 pusher BI 10 65 pusher ADL
164. OT 31 AJRAL X DIIPIIEN k V MTORR A 38
165. 1 40 10 0 7L 2 59 0 5L 1 1 8 10 36 10 4 92 2 2 10 1L 81 8 2L 100 3 4 1 2010 Rs 53 100 90 80 m 420 7096 10 lt E 20 m5 lt S 10 60 m s 5 gt 2 10 50 10 gt 20 3 203 40 30 20 10 1 2 3 5 8 3 10 1 2 3 5 8L 30 2 73 6 90 6 100 100 1L 90
166. 8 49 33 37 2 tor 21 4 9 HbAlc 1 2 HbA1c
167. ABCDE airway amp breathing circulation dysfunction of central nervous system environmental control decontamination ABCDE drug
168. i Penske ties 1 8 1 2
169. 4 1 2010 25 aOR RR II AY FTE RE IO a he BAKE U SCANNER TI m U SCANNER II m U SCANNER II m o PBESEAS5096 c Clubs SHR 9k m 25 103 ACFE Clinical research 4 1 2010 3 KEES OEE COATT FLAN SB bi
170. X 1 16 D D 2004 26 476 479 2009 31 531 537 2 2006 258 269 4 M H Marchant Jr N A Viens Chad Cook et al The Impact of Glycemic Control and Diabetes 2 3 Va Mellitus on Perioperative Outcomes After Total Joint Arthroplasty JBJS Am 2009 91 1621 1629 WHER PIERE FHER fi JpnJ Rehabil Med 2009 46 793 798 Sunaga K Miura K Naruse Y et al Glycated He 5 WV 6 moglobin and risk of stroke ischemic and hemorrhagic in Japanese men and women Cerebrovasc Dis 2008 26 310 316 7 1 XOE3 2008 74 76 4 1 2010
171. 2 1 4
172. CRP CRP 12 94mg dl AME Na 129 5mEg CA125 311 3U m 1 CT 1a 33X25X17cm MRI 1b 33cm FDG PET 1c SUVmax 4 28 GIST 4 1 2010 imatinib 400mg H amp 2 FDG PET SUVmax 2 08 mi 1d FDG PET imatinib FDG PET imatinib 2 4
173. 5 4 1 2010 5 6 1 3 1 27 4 1 2010
174. IABP ACT 200sec heparin nicorandil 3 6mg h clopidogrel 75mg aspirin 200mg carvedilol 10mg telmisartan 40mg pravastatin 10mg CK 10 4731 IU 1 3 IABP heparm nicorandil 15mg day 7 7 II aVF ST 3 aVR 3 7 4A 4 1 2010 4C CAG PCI CAG RCA seg 1
175. MIB1 index 8 10 10 coagulation ne crosis high risk 18 imatinib400mg 5 2008 10 12 238 3 a HE b cit c ki 67 Gastrointestinal stromaltumor GIST 1998 Hirota c kit GIST KIT GIST GIST CD34 c kit
176. a t BER A BET Tix 3 6
177. 21 2 4 10 f 23 23 4
178. 2 22 54 CT CT OCT 2 1 75s 174 23 9 CT 24 VEO WEES 10 CT 1 3 CR
179. 3 ag PDA 22 2 WI 517 330 6396 PDA 20 22 2
180. FEAST CT TAE 157 4 1 2010 Transcatheter Arterial Embolization TAE D GCS Glasgow Coma Scale EFLIN GCS8 2 Cushing
181. 28 51 55 38 59 7 5 BR ul SS 1 92 ADL PT 1 EROR m ux S ul Se 4 1 2010 10 CT PT ADL 1 PT ADL 1
182. A A A A A
183. CPC 3 3 MS Word MS 10 5 1 2 3 4 35 5 SI FBS 110mg dl
184. PT X E 1B J Ss am 1A X 4 1 2010 1B PT X PT 2 50 PT BAA RDP 024 56 SpOz 96 PT 02 WE hE PT program ROM NENNEN BENBNNENEENENEMEMEMENEABIENENEIEIEIEIIMN t E EEENNNNNNEEEE 38 1 2 PT BOA 35
185. A A 2 A A
186. 1982 2007 9 75 91 81 1 BMI16 9 kg mz 9 7 8 1 5 4 5 2 28 72 55 1 a b 18 67 2 75 F 16 44 3 83 F 16 44 4 86 F 16 89 5 91 F 16 2 6 73 F 14 67 7 83 F 19 9 8 75 F 17 35 77 F 15 6 22300 5800 12500 0 3 10500 7 19 8500 11 23 12700 13 48
187. 4 1 2010 Tamponade Airway obstruction Flailchest Tension Pneumothorax Open Pneumothorax Massive Hemothorax TAF XXX C
188. x R 1 HARRI TALS AGE 4 1 2010 34 33 36 2008 2 Infutest2000 31 122 124 2007 3 Vol 75 No 4 2005 4 DX Vol 78 No 4 2008 5 EE RR a Vol 75 No 4 2005 6 TIE Vol 75 No 4 2005 7 Vol 79 No 7 2009 8 Se 3576 KH ME Vol 79 No 7 2009 Xr
189. 3 IPV 3 IPV IPV
190. 5 HT 5HT AMI PCI AMI CAG Ach AMI NCH AMIGO HG EMRIC L ee Ee 80 RCA
191. benign form2 18 71 CT REN dirty fat sign 4 1 2010 19 SUERA 83 CTO scout view HADNA RREO N CT EREE 20 74 CT S 2 OK CT CT SMA S
192. 167 4 1 2010 2 Boerhaave 75 CT 2009 03 03 11 11 03 0003000011310628 3 HORMEL 40 CT free air 4 TRIBAL 47 CT lt CT 4 cm Ra Fiir oE leak 5 AIDEI 72 CT S
193. ADL ADL ADL 1 Brunnstrom stage
194. 1 5 MRI 6 11 141932 7 D 20064F x CO BH 2E tli E400 1932 1 1998 12 16 2 1999 1 2006 12 78 9 5 4
195. 2a 1000ml GIST iT EAE OBR ir Ar 3 OUR 6 22 7080g 3 600ml 3 400g 2 a REGES HORE RA EB ik A DEUJ BR EPMA AUR frt 5H ht amp do c b 260 X 280mm 3 400g 30 260 X 280mm 2b c kit CD34 Desmin SMA S100 V GIST
196. 4 17 CT 14 SEREK 56 CT 171 4 1 2010 15 36 CT amp EEO RSA CT 16 62 CT IBI ROSSO 218 17 75
197. BT imatinib sunitinib imatinib GIST 1 ffl GIST 33 iE 61 X 2008 3 2 CT CT 22cm BEEE 169 8cm 51 1kg 37 4 123 84mmHg 107bpm HER ARE If Wael
198. KE 24 RE gt 4mm 2 19
199. QOL X B 1 PT 2008 42 915 924 2 2002 12 82 91 3 PT 2008 42 925 931 4 EH H HEEBP 2006 154 155 4 1 2010 Pusher JE E TEE Z ELA BUA HB LAG RED 1 el Mp ZEA Pr EEO Activity of Daily Living ADL pusher pusher ADL RE pusher
200. PT 11
201. pusher ADL ADL ADL pusher ADL X 1 Pusher 21 1 1994 2 PM Davis steps to follow 1987 3 Brunnstrom S Movement therapy in hemiplegia A neurophysiological approach Harper amp Row New York 1970 4 Mahoney FI Barthel DW Functional evaluation the Barthel index Md Med State J 14 61 65 196 4 1 2010 9 187 ME
202. GIA f flow 4 0 X 15mm 20atm 4B PCI ST carvedilo1 diltiazem 200mg 8 4 1 2010 19 diltiazem nicorandil CAG Ach Pm REEN 5A VUS RCA Ach 20 g
203. SD 2 Modulation 2 1 60 Modulation 112 Modulation 123 60 80 130 650mA 40 80 Modula tion 60 80 100 150 130 650mA 40 60 Modulation Modula tion SD 2 2 Modulation Dose Length Product DLP CT DLP Modulation
204. free air 6 66 CT Whirl sign F R 168 t E 7 CARH 79 CT GR CT
205. 71 73 2 74 162cm 62kg 74 126 72mmHg 3 2 4 1 2010 IVC NCM SHC AEA 4 AE crista terminalis CT IVC CT IVC CT NCM 1 ue p i Uu 4 2
206. ERCP B 2 IAG ORELB3 CT MRCP hepatic peribiliry cysts 7 4 1 2010 FAY 2009 9 C1 cystadenocarci noma 7
207. 10 10 9 0 10 10 10
208. 3 3 1 1 3 2 143
209. PT 3 PT PT WIE 3 PT VRAIS Ra DPRE SS PRB AR LE FETE V 4 1 2010 ADL BO
210. R CHOP QOL 160 X 1 Coiffier B Rituximab therapy in malignant lym phoma Oncogene 2007 26 3603 3613 Rummel MJ Chow KU Karakas T et al Reduced dose cladribine 2 CdA plus mitoxantrone is ef 2 Va fective in the treatment of mantle cell and low grade non Hodgkin s lymphoma Eur J Cancer 2002 38 1739 1746 Armitage JO Tobinai K Hoelzer D Rummel MJ Treatment of indolent non Hodgkin s lymphoma 3 wer with cladribine as single agent therapy and in combination with mitoxantrone Int J Hematol 2004 79 311 321 4 Konar A Brown CB Hancock BW Moss S Pro tein losing enteropathy as a sole manifestation of non Hodgkin s lymphoma Postgrad Med J 1986 62 399 400 5 Kaneko H Yamashita M Ohshiro M et al Pro tein losing enteropathy in a case of nodal follicu lar lymphoma without a gastrointestinal mucosal lesion Intern Med 2008 47 2171 2173 6
211. 2009 7 18 82 125mg 250mg WL BaeAbit rok 160cm 56kg 35 7 C M139 96mmHg WREAI36 27 x UV NRE L HR Meee NEU Hg Wheeze WBC 11 5 X103 u L CRP 2 18mg dL amp 2 UE LDH246IU L 151mg dL 5L h pH 7 256 PaCOz 59 0torr PaO2 64 5torr HCO3 25 6mmol L BE 2 6mmol L X Ne
212. URL 6 Co 1 2006 95 2289 2291 GrazianiG SantostasiS AngeliniC etal Corticosteroidsin cholesterol emboli syndrome Nephron 2001 87 371 373 2006 1293 1298 1 4 internet accessed 2003 01 26 http www2 hama med ac jp w3a toshokan oldkanpo hikumano36 html first 1 MS Excel MS PowerPoint 1 1 2 X ECG EEG 3 4 5 6 B
213. XE 3 5 20 60 4 DM PT DM 1 3
214. PTD Preventable trauma death ABCDE Airway Breathing Circulation Dysfunction of central nervous system Environmental control Pri mary Survey PS Secondary Survey SS Preventable trauma death PTD Primary Survey PS Secondary Survey SS JATEC 5 Tertiary Survey Japan advanced trauma evaluation and care PTD Preventable tra
215. TDS 2 1 200 fill 20 26 520 3 4 1 2010 B HORRUEARITDZS A RUERUIEAD 27 I 2 VIE ORO E B B B Re 8E E 1 2 3 4 E am a 7 2 a 8 ia G amp ew aw AN 5 TTS30 1 x 4 TTS20 1 A x 2 TTS10 1 A x 2 B 1 de eS F3 1 B 1 EEA 8414471 941 494 580 293 50 40 30 20 10 15 19 20 24 25 30 2 2 5
216. ME MARCS MARCS web MP 4 1 2010 5L 1L
217. 122 1 1 4 1 2010 Tes 123 1 5 3 1 O O 2 O O 3 O 4 O 5 A A 6 D Na O O A 7 Na O O 8 Na O O A 5S 3 3 1 318 3 2 219 3 16 2
218. 3 4 55 ER 39 16 41 0 28 18 64 2 10 24 41 6 1 3 30 23 76 7 5 M6 15 10 b E amp 5li E E 1 2 3 4 5 5 SERIE CR IOUS 30 ro me d BRE 0 lt 6
219. Pee NOS EER
220. V 9 9 4 1 2010 9 5 2006 4 2007 1 2007 4 2009 9 91 66 57 10 53 13 52 6
221. ambroxol hydrochloride 2 CM CSE 15 3 20 60 70 6 12 9 GM CSF
222. CT SS E deadly triad fa MITRA 4 Secondary Survey SS PS ABC GCS 8 SS CT CT AMPLE Allergy Medication Past history amp Pregnancy ME Last meal Event amp Environment
223. 0 7ml kg 140mg kg 1 0 35 ml kg 70mg kg 17 72 safety self scene survivor 3 8 4 1 2010 ABCDE decontamination
224. S 4 1 2010 5 1 1 5 1 1L 0 8L 1 45L
225. StageIV 2 Graus 3 426 500 14 6 244 256 5 8 31 6 CH 28 5 2 DIC K
226. THA TKA Marchant Ameri can Diabetes Association Agency for Healthcare Research and Quahity 2 28 1 97 3 42 Sunaga 9 3 6 HbA1c HbA1c 5 0 5 4 HbA1c 6 2 7 3 fF HbAlc 7
227. 21 1995
228. 4 1 2010 ABCDE airway amp breathing circulation dysfunction of central nervous system environmental control decontamination ABCDE drug 5 000 7 8
229. 96 PCT 99 IPCT 99 PCT 41 IPCT 47 59 PCT IPCT PCT PCT 107 4 1 2010 PCT 2 PCT PCT
230. e 4 Cr 4 e ES REX Ail 4 I TI 163 4 1 2010 I Cx 5 9 6 7
231. 2 3 6 fx 1998 12
232. 18 3 20 3 1 21 1 6 21 3 27 3 1 1 Wa AN Ab Mel 700 60 30 150 Cancer Board
233. 4 1 2010 3 MEAT IPV 9 IPV IPV 96
234. 75 9 7 2 6 2 1 GIST 5 25 55 5 7 40 4 29 Tcell 17 B cell 12 6 Bd 5 Kina RA CHILI SGA HBO e 028 TLT BGA CHB AMO HB A AEE FC k V BFL 2 H
235. 4 3CCD A B C US3100R 101 4 1 2010 1 1 iE 10 HPF 20HPF eT 1 5 HPF 3 1 HPF ME D
236. Weg PIAS ita bn 9 CBd12 R ZORILE Mo TERALA 2 2 5cm 10 13 10 90 CT whirl sign 223225 5 Ela ds 2E 115 IS LILTIIJ 11 83 CT CT BEANS AA RIE 12
237. A A 45 A bhal 0 U7z A 80
238. PT PT fait PPA PIL Become LL FRI bok PT S 3 3 X 1
239. 4 1 2010 BUN Cre 20 3 tk Marchant5 Total hip arthroplasty L4 FTHA We Total knee arthroplasty TKA 18 0 15 1 549 1 032 039 WS THA 10 0 19 3 1 551 3 2 2008 BHA 2006 2008 2009 2 3 6 2006 2009 4 2 1 2 CK BHA 2006 0 0 37 2007 0 0 34 2008 0 0 35 2009 3 6 2 55 4
240. 5 0g 2 1 22 2 19 1 100ml 2 4 2
241. ECG mA Modulation 64 CT LightSpeed VCT GE JIS 3100 ivy ECG 40 60 80 100 120 150 ECG mA Modulation 232 CT Modulation standard devia tion SD 1 Modulation Modulation 130 650mA 75 Modulation
242. Ize 3 4 PC NANDA NANDA 5
243. 4 1 2010 Non Contact Mapping 2 Pil BT WE RE mU RJA HERO Non contact mapping NCM geometry far field potential
244. 3 2004 pp 153 158 3 J 2010 92 2 262 266 4 2006 10 4 16 20 5 2004 89 4 388 394 Original articles 4 1 2010 18 ME
245. X 1 Forrest M Bird amp PV 12 2 58 60 2006 2 IPV http paonmedical com ipv 03 html 3 3 8 790 795 2005 4 1 13 1 249 2008 Au Gg Short report 4 1 2010 2 MAY pH 9 2 9 2 2 2 2 320 24 KOFLOC 10 36 10 4 9
246. A 1L min 5L min TOMH 0 5L mn 5L min 15L min TOMA 1 0L min 1L mmn 1 2 3 5 8L 0 0 2 2 0 4 2 2 9 2 9 3 3 2 9 95 1L min 2L min 1L D 8 10 A 20 B 1 20 C 20
247. 4 1 2010 1 2 1 S SS Ss lt H Review articles 4 1 2010 e ot ERCH S 2 887 IRAN EIB AR ig iit Hp OUR V ERRIRE AGED ST
248. 55 432 0 24 58 039 0 30 1 845 1 41 1 1 2009 11 2010 2 4 1 2010 55 18 15 42 66 17 2 53 20 11 5 4 4
249. MD 7 wp Mp wp RE ADL ADL
250. 1 2 CT HOD 7 MPM ERS C PASEO TAS amp 3 2 2 CT BUN Cre 37 9 45 6 58 2 76 RRRA 21 9 HbA1c 2 6 5mmCCS 2
251. 150 Ambulatory Therapy Center ATC 60 ATC ATC IC
252. AMI PCI PCI L lt t tret CR Ce SER e E Achlz k 20e SERES HEAR CIE amp 7k PCI PCI PCI
253. The Journal of Hamamatsu Medical Center 3 1 31 4 1 1 1 1 17 4 3 9 CPC 1 4 41 21 24 18
254. Vol 76 No 4 2006 10 A KH Vol76 No 4 2006 11 C Vol 76 No 4 2006 12 Vol77 No12 2007 13 FTA FMTA Vol75 No7 2005 9 TE ER ET Case reports 4 1 2010 1 BIEL AR h 355 at ET AR PRR DEAS CRESS CHAIN fT DAV Co S WUE CHS LZ U ESSA SEU HE n ESEJSPU BLAU 7z TIR E SAIS FEBR U ER A ESSE tao HH e TUAE SITES 8 d dH EDS SEI C 7x lt RIERA EDEL ORADE OWERNII ko CHU te
255. 1 it w S E 73 40 REZ 20 3 4 X50 10 X50 21 12 20 P 101 70mmHg 72 39 2 CRP 1 1 WBC 8100 mm LDH 282IU L CEA 14ng ml RBC 404xl04 mm y GTP 234IU L CA199 19U ml Hb 145g d ChE 146IU L HBsAg Ht 419 BUN 130mg d HCVAb Pit 124x10 mn Cre 0 78mg d ANA x 40 PT 100125 Na 138mEq d antFM2Ab lt 5 APIT 115 7 K 3 6mEq dl TBil 0 96 mg dl Cl 102mEq dl D Bil 0 35 mg dl TP 7 1 g dl AST 72IU L Alb 3 9
256. imatinib400mg 1 4 1 2010 imatinib400mg imatmnb w sunitinib 5 PD sunitnib 1 33 64 84 41 85 1454 4 12 1 2 6 0 F lt 50 3 9 1 0 0 0 50 lt 70F 13 39 4 0 0 0 70 17 51 5 4 23 5 lt 2 0cm 6 19 4 0 0 0 2 0cemS 5 0cm 15 48 4 0 0 0 5 00m 10 0cm 5 18 1 0 0 0 10 0cm 7 22
257. Coffee Bean CT whirl sign S 5 Bilbtetiie 10 S C CT S 169 4 1 2010 8 11 MRI
258. WBC 5400 u L CRP 0 17mg dL D glucan 10 1pg mL Aspergil lus Ag Cryptococcus Ag Candida Ag HIV Ab X 2 Tik A FA u k CT 3 5mm S WX AJ 1 3 WR O0 ROMA EMD 7 WILY TRON 2 X a 3 CT 3 10 4 1 2010 1 Nocardia asteroides PCG ABPC CEZ CTM FMOX IPM CS GM EM CLDM MINO VCM FOM SG 4 CT 3 2 4 6 Hd dd DA Ba
259. 10 150 75 1 13 15 3 95 28 67 41 7 20 0 15 95 4 2 6 3 1 45 54 11 12 OS 3E 7 50 100
260. 1999 53 567 573 22 fli DOTT fi ERKO 2 1998 31 71 75 23 CT 1998 1 603 24 2009 63 285 294 25 ZHZ WH WDA fti glove perihepatic packing b 1 2009 3 115 119 12 ERP 1 fill 2000 54 1005 1008 2009 63 309 316 2009 71 283 285 C 1
261. 2L min 1L 10 10 KOFLOC 1 2007
262. PCT 5 4 1 494 412 83 4 406 98 5 99 30 30 3 382 96 7 15 SD9 7 8 SD7 8 2 65 31 1 29 106 5 60 2 4196 442
263. Tumor Board 118 1 TDM 50 1 60 28 35 2H 4
264. 1 2 OT OT 1 PA RRR HEP Bia PAS 2 ADL fj
265. 10 7 4 7 18 990 18 48 6 12 32 5 10 1 10 1 2 3 4 5 7 8 10 14 15 16 18 4 4 1 2010 mmHg 700 600 500 400 300 L L L 1 L 1 L L L L i 1 2 3 4 5 7 8 10 14 15 16 18 5 120 100 080 060 0 40 0 20 00 1 2 3 4 5 7 8 10 14 15 16 18 Bde 1 1400 p 1200 1000 800 600 400 200 1 2 3 4 5 7 8 10 14 15 16 18 7 1
266. FREAK FcR EMESIS EAS I lt 7x 1
267. H21 10 31 11 14 2 30
268. 4 1 2010 27 IMV 487 CT CT S dirty fat sign23 5 5 212 IMV air CT IMV CT vi oncologic emergency 1
269. Schinitzler 2 colitic cancer 28
270. 4 1 2010 Up to Date NP nurse practitioner NET Up to Date Up to Date
271. 4 000 1 400 2 300 5 10 5 Clinical research 6 000 1 400 3 5 10 6 Special articles 8 000 1 400 5 7 Field activities 6 000 1 400 5
272. B2 EOE L RRO B3 6a hepatic peribiliary cysts 6 b B2 NBD 6a ERCF 6b ERCP 24 4 1 2010 hepatic peribiliary cysts 1984 9 9 73 hepatic peribiliary cysts
273. FIM FIM C x 2 FIM 18 3 FIM 25 C p REA 25 50 50 75 75 27 GCS E4V1M4 BRS HV V I Il V W V FIM 13 5 46 OT
274. 2 2 21 21 1 4 1 33 4 1 2010 1 21 2 2 PC PC NANDA
275. 4 NIH Consensus Conference 9 27 3 high risk high risk 4 44 4 high risk C 5 gt 7 high risk 8 8cm 1 2 2cm 15 50HPF high risk matinib 5 2 2 PD 3 imatinib high risk
276. 4 1 2010 avL aVR aVF 1 2B CAG PCI 6 ST STEMI primary PCI CAG RCA seg 1 2A TIMI Grade3 flow 2B 3 5 X 20mm BMS 4 0 X 24mm 11atm 2C 4 0 X 15mm 18atm 2D stent 2C IABP 2A RCAseg 1 2D PCI ST
277. gj 31 WM B 1 HN BM B 1 2 2 3 PCT PCT 91 6 3 CHO 46 26 47 18 45 16 PCT 34 19 PCT 36 21 PCT
278. 145 4 1 2010 CPA 16 Te
279. HOUMA 51 3 2005 43 49 2 Helen J Hishop Jacqueline Montgomery 4 1 2010 7 3 vol 8 no 1 2006 37 44 4 1 2010 IPV Intrapulmonary Percussive Ventilator 1 TE 51 Intrapulmonary Percussive Ventilator IPV
280. 147cm 42kg 130 76mmHg 70 36 4 HOH Ze L AIRES VSB 10mm 2 CdA R CHOP WBC 5200 1 neutro 79 1 lymph 12 6 mono 6 0 eosino 2 1 baso 0 2 RBC 454 X 10V zl HGB 123g dl HCT38 7 PLT 19 5 X 10V ul RET 16 7 TP 4 7g dl ALB 2 9g dl T BIL 0 62mg dl D BIL 0 17mg dl GOT 26IU 1 GPT 35IU 1 ALP 174IU 1 LDH 247IU 1 y GTP 46IU 1 CHE 194IU 1 BUN 14 4mg dl UA 4 6mg dl CRE 0 69mg dl Na 140 7mEq 1 K 4 1mEq l Cl 106 1mEq l Ca 8 1mg dl P 4 3mg dl TC 188mg dl TG 61mg dl BS 120mg dl CRP 0 02mg dl RES 7 SB grade1 47 XX t 14 18 q32 q21 der 18 t 14 18 19 20 46 XX 1 20 FISHY lgH BCL2 76 CD20 92 1 x H 7 1 A H 65 3 A monoclonality 46 XX 20 20 CD45 blast gating CD20 83 3 x 4 9 6 A H 67 4
281. 2 3 1 B 1 4 A 5
282. 2007 2 40 IL P221 223 2009 3 2008 4 vol 31 No 1 P96 100 20064F 111 4 1 2010 64 CT ECG mA Modulation oh Aa ECG mA Modulation ECG mA Modulation Modu lation standard deviation SD 80 5 RE CT ECG mA Modulation c
283. 4 1 2010 X 1 2009 2009 2 CLINE CAL REHABILITATION Vol16 No7 2007 3 4 75 86 2004 4 CLINICAL REHABILITATION Vol18 No11 2009 5 34 4 174 177H 2007 132 4 1 2010 Aiea 2009
284. ADL ADL PT ADL PT
285. B 6 B 1 2 250mg dl 3 90mg dl 1 2
286. Ver 6 X B 1 5 S JIPM 2005 2 5S 2000 124 4 1 2010 2 8 3
287. 3 RCCHOP 2 CdAZ 5 4 1 2010 2 CdA MIT cladribine 5mg body day1 4 mitoxantrone 12mg body day1 0 30 60 A 2 RCCHOP 6 1 R ANTERIOR L 24h L 3 R CHOP 6 4 4 5 62 CD20 7 2 s 6 5 5 495 6 12 2 CdA
288. 55S 18 4 58 21 5S 17 10 1 5S 1 D Ver 5 5 S 18 4 5 S 2
289. 43 57 4 1 2010 PCT PCT PCT 7196 6 E5185 27 PCT 74 23 C 0 E B 6 3 PCT PCT 97
290. Jeo NR TAP Of CE e ST 2 AO Ar bd 4 E 1 50 10 20 40 BE X 8 X 2 9 18 2 1 4 mg 7 5 g 3 9 25 X 1 3 2 80 BRI X 37
291. 1 2 2 1 3 3
292. 3 BA UA Bt a ER 2 9 PT Activity of daily living ADL LUC PT PT Quality of life QOL PT
293. 4 1 2010 Be Lx A 1 e we 75 1 LVEX B a Nocardia asteroides ST RA
294. 4 4 11 workig space HH 36 SA se S p C Belk ata 0 2180 RE fai UC 35 0 Jara c JU sio Ze A gt 72 REOTEUS E E 8b 7e DASHA gt D ERE e BED FIT Fo ld 2 2 5 75 dats amp RR LERT 2 c ASE amp HEDRO IE PERS E IS Kit TA Cb O AACE A CX 63 Bd 5 5 PARA Ic SHA Se1 80 X60mm Se BI 5 mm 1a 4 1 2010 4 3
295. GIST gastrointestinal stromal tumor Gastroenterol Endosc 2008 50 1597 1604 7 GIST gastrointestinal stromal tumor 2009 3 23 29 2008 41 1661 1668 Flecher CD Berman JJ Corless C et al Diagno 2 WN 4 5 Wa 8 9 sis of gastrointestinal stromal tumors A consen sus approach Hum Pathol 2002 33 459 465 10 Dematteo RP Ballmann KV Antonescu CR et al Adjuvant imatinib mesylate after resection of lo calized primary gastrointestinal stromal tumour a randomized double blind placebo controlled trial Lancet 2009 373 1097 1104 11 GIST 4 1 2010 12 13 14 W 2010 65 1 100 106 Demetri GD van Oosterom AT Garret CR et al Efficacy and safety of sunitinib in patients with ad vanced
296. 2 3 7 27 28 36 3 1 2 ADL 3 ADL 1 PT PT 2 CLK
297. ADL 3 Gl 1 4 1 2010 1 preventive 2 restorative
298. 130 1 5 2 DM HDL
299. 2 ATC
300. 166 FEDS TEND lS SOA HS 4 FABER EL d 4 OD L 9 X free air 5 CT low density 9 5
301. 3 2 HOKKE X Mlk Nocardia asfero7es 1 Nocardia asteroides 3 15 ST ST 4 6 CT 4 Mycobacterium intracellulare PCR Mocardza asteroidest k U My cobacterium intracellulare 55 4 1 2010 Actinomycetales Nocardiaceae fifi UC Nocardia asteroides N brasiliensis N otitidiscaviarum N Farcinica AM astero
302. 4 1 2010 1 2 Ral HAR 2
303. Femoral neck fracture Bipolar hip a arthroplasty Cerebral infarction Diabetes mellitus bipolar hip arthroplasty BHA 2 1 69 20 X 50 21 12 HETRE U ZEIT HbA1c 7 7 3 BHA 1 1 X 67 355m1l 225 353mg
304. 9 Boudouresques 431 53 12 McCormick 121 3 2 5 RKane 4 802 4 6 26 2 2 9 17 7 1 1 11 1
305. 1 6 2 FIM ADL13 ADL5 1 7 7 ADL ADL 3 4 AGRE X B 1 ADL 2004 67 68 2 2005 88 93 3 37 6 2003 600 603 4 SIAS FIM 1997 48 53
306. 19 CCU 75s 2 4 1 VTE VTE GORA BE 0 2004 2005 2006 2007 2008 2009 4 1 3 31 VTE venous thromboembolism 1 2008 4 2 2
307. 2 3 75 HABE PUK IC CHR SEARO ET CA BE MRI 9 8 1 4 55
308. 42 41 0 64 2 41 6 60 48 3 40 7000
309. PCT PCT PCT x B 1 2009 11 12 2 2008 18 464 466 lt OF 2006 8 20 28 VN 3 108 4 1 2010 ult B
310. 2 CT XU YORK crazy paving appearance B5 BAL B4a 2b PAS BALF 3 WBC 7 5X10 5 ml macrophage 72 lymphocyte23 neutorophile 2 enosinopile 3 CD 4 8 1 61 SP D 3 DBALF 65ml 150ml 13100ng ml SP A 496000ng ml GM CSF 8 0 0 4 GM CSF room air pH7 439 PCO 43 6 Torr PO2 60 0Torr HCOs 28 9 mmol l BE 4 1mmol 1
311. 4 1 2010 756 kk BMTTF ALUT
312. 7 225 444mg 200mg qdl 30 BHA Bd 3 A bake BHA 3 X 4 1 2010 147 530m1l RCC LR 4 2 4 13 CT 4 AAA 4 CT BUN Cre 46 3 70 4
313. Bilroth II Was FLO 1 HB Zss 2008 69 2877 2882 Koch P del Valle F Berdel WE et al Primary gastrointestinal non Hodgkin s lymphoma ana WV 3 4 5 7 tomic and histologic distribution clinical features and survival data of 371 patients registered in the german multicenter study git nhl 01 92 J Clin Oncol 2001 19 3861 178 we wa 5 1995 1999 at 2001 36 871 881 FLEK 2 81 IRYO 2005 59 324 328 FATHER TESHIER ASA fih T 2 2007 104 388 393 oncologic emergency 2009 71 708 713 PMX DHP ICU CCU 2010
314. pulmonary alveolar proteinosis PAP 100 HUT MERRIA AIRG CM CSF autoimmune pulmonary alveolar proteinosis CT 167cm 57kg 129 99mmHg Sp02 97 room air 77 35 6C 261 fe JE 62 1 WBC 8300 TP 7 3 g dl S2 RBC 342 10 4 yl Alb 4 g dl a Hb 15 7 dl T
315. 30 64 P 31 64 P CT S 20cm P CT radiopaque 4 1 2010 VW 1 CT MRI 5 7 23 26 27 2
316. ANAT 1 7 3 e C MRSA e S e 2 v PEEP PE e EA e CPA 1 CE
317. DM REBBE bN DONDA CRE Z lt WHE LCS MRE Nea A DM PT DM PT DM 2008 19 DM 890 DM 1 320 20 4 7 1 DM 3 DM PT
318. OE oth RIR fr 3 Gott OKAM CAT M 4 FBC REAL Cfr ME OREH 8E xot 5 Quom CF OREM Cfr BE Quz Gon 6 76 ORMADRA DIY X4UXdD B CH 20 200 178 21 4 9 100 69
319. 11 94 3 12 93 6 2 95 2 4 1 2010 5 S 3 5S 2009 10 TPM 5S 5 S 5S
320. 2 E 42 Gastrointestinal stromal tumor GIST 1 45 hepatic peribiliary cysts 1 Bb 1 55 1 o iti 65 1 5 69 3 72 75 Pusher 1 78 81 IPV Intrapulmonary Percussive Ventilator 1 S 84 88 92
321. 2008 41 682 687 30 Abba sc MATE colitic cancer 2006 17 20 4 1 2010 1 2 1 1 1 2 2 1 2
322. 0 43 0 02Mp 5 Mp m 10L 15L 241 2L 11 15 53 320 10L 24 NICU 10 20 20 2 B ma s 241 100 90 80 m 20 lt 70 10 lt 205 mas lt E 10 60 m s m 5 gt 2 10 50 10 gt 2 20 m 20 gt 40 30 20 10 0 t 2 1 5 8 2 10 1 2 3 5 8L 46 5 63 1 68 9 94 6 90 9 SLE 8L
323. 10 8 MESH o 2 1 10 650mA 130mA 650mA 1 5
324. 2 6 20 4 1 2010 0 30 60 90 120 150 180 4 2 CdA MIT 6 5 CT 2 CdA MIT 4 CD20 rituximab 2001 CHOP R CHOP R CHOP 1 R CHOP PD Progressive Disease NST Nutrition Support Team Po RE
325. 4 1 2010 97 U SCANER II 101 3 106 109 64 CT ECG mA Modulation a 112 118 5S 122 125 129 133 138 141 AH 143
326. 5 4 1 2010 20 Br stage pusher on elbow
327. 12 5 2007 4 2009 9 91 66 25 5 WHO CHS AE nate 2006 4
328. 40 DX 19 Ai Autopsy imaging Ai Autopsy imaging 21 24
329. drug 21 9 7 Up X 1 2 2001 2 http www j poison ic or jp homepage nsf internet accessed2010 3 25 3 http jsct umin jp page037 html internet accessed2010 3 25 161 4 1 2010 Wr Ai Autopsy imaging
330. fli GE Today 2005 Sep 17 20 4 YAR MUE CT Angiography 1 64 Cardiac CT 2007 1 19 5 HE CT PR MEDICAL VIEW 2008 11 6 16 6 MEDICAL VIEW 2006 6 6 12 7 1 GE LightSpeed VCT CT 2009 02 10 21 2 115 4 1 2010 DHT Field activities 4 1 2010 AR 21 1 21 3 3
331. 2 3 4 146 4 1 2010 1 8 CDEJ 40 3 QOL
332. 2 1 756 PT 1 234 H ho ALIS CMSA SH BU U Ze Ze 4 5 6 8 w BR Bh a S PT 9 10 16
333. 7 OT es 7 3 key person 4 1 2010 1 1 CT GCS E2V1M4 1 Brunnstrom stage BRS lll IN Il ZEV V V 13 ADL 2 Functional Independence Measure FEIM 13 5 OT Range of Motion ROM
334. ADL 3 3 OQ A A Bok 110 A
335. X 20 X 10 X 5 X 3 Hb7 8g X 2 X 1 1 X 1 8 X 1 8 2 5g 1 1 15
336. CPC R HR ME a W Ho E TR JR uS pr E SF FF A AA x qu ck R BH de FF 188 pd The Journal of Hamamatsu Medical Center Vol 4 No 1 2010 4 1 22 1 22 22 12 1 T 432 8580 328 TEL 053 453 7111 T 433 8119 30 24 TEL 053 414 3962 189 44 1 2010
337. CT fH low density area IU rs 5 5 APERA 18 CT CHS ABRO I Br S HH a RE OD HEUS sonolucent layer HAZZOWER IER HAORA 17 9 MRCP 6 SU MEHASE ZS 19
338. PT SHE MRI 1 WY y FRYE CLS FEE IK OEE AES UI MRI 10 Th10 MMT 2 2 3 2 10 4 1 2010 MMT Manual Muscle Testing E E E 5 Normal 4 Good 3 Fair
339. X127 909 C S GEA He HH HAR WAGE ERE HO X K 26 SMA 37 CT CT SMA SMA SMA 1795
340. 4 9 4 10 HCV AFP 3698 3 ng 1 PIVKA II 69800 mAU ml CEA 8 8ng d1 11 x 8 cm C TAE 4 14 TAE CT 755 TAE 2 Low dose FP 5 FU CDDP 2009 2 2010 11 26 FE Low dose FP PD 3 T UFT 2009 7 5 TREC EEE L MERRIES A
341. 66 CT 2 cm 170 A HI 13 PEM 16 CT target sign Iii ZJE 1 TEREX 14 CT Dirty fat sisn HS CT
342. RAM RR EB UK WA KA RERO vg ge 61 CT 33 X 25 X 17cm GIST imatinib 2 MBO ME ifs LCA FE EB iA DEGUER 1998 2009 GIST 33 4 2 5 imatinib 1 5 5 2 imatinib f gastrointestinal stromal tumor GIST imatinib Gastrointestinal stromal tumor GIST fj ckit
343. nontuberculous mycobacteriosis NTM Nocardia asteroides ST AMyco ac terium intracellulare PCR NTM REFP 3 NTM 3 NTM
344. 18 1 D BAK RAMOPPR AMER Baas PT 70 MMT 0 10 ADL 100
345. 3 4 Vol 33 NO 12 1999 p1131 1137 4 1 2010 1 8 710 LK 62 X CT BALF OKO amp ETHER EIU Hi GM CSF CT GM CSF
346. 130 650mA modulation40 60 CT SD Modulation SD 80 5 Modulation LightSpeed VCT 2 3 Modulation 80
347. 28 8 9
348. 3 63cm 12 4cm 12cm 100 5 21 8 12 3 9 9 laparoscopy endoscopy cooperative surgery 8 10cm 6 2
349. Glasgow Coma Scale E1V1M4 Brunnstrom stage Br stage 2 AFL ARI 1 ADL BarthelIndex BI 3 0 1 stage II b B4 StagelV X2 Brunnstrom stage 6 stagel V stage 3 BarthelIndex ADL B5 StageV 4 1 2010 B3 Stage 0 100 3
350. 6 1mmo1l 1 SI 6 7 8 4 4 000 6 000 12 000 1 400 5 x 1 2 3 2 3 letal 3 Index Medicus 4 180 4 1 2010 7 3 4 3
351. HH ded MEO X REL IL AXI ZETA amp UCHR BE HHAEOO MAC k5 EBRO REDAT d 5 Gross ld WER amp HABE amp HH SE ASAD IA ORT PMICN AUC Te BBH EEOZ2 FASE SAR Cl 52581961288 53 599 HE 9 Carter5 180 180 9 8
352. 1 Modulation SD 30 70 RR 75 Modulation SD 1 Modulation e 40bpm 130mA Lowe 40bpm 650mA Full 40bpm 60bom amp 80bpm 100bpm E 120bpm 150bpm e oe eG ge 0 5 10 15 20 25 30 35 40 4 50 5 60 6 7 75 80 8 90 95 ecor 1 120kV 130 650A modulation75 Modulation Modulation 5 4 1 2010 2 1 60 Modulation 80 5 2 7 7GObpm 7 80bom 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 Recon 2 60
353. 2 147 4 1 2010 1 1 1 PERM ESAE TV ATF eye O ERROBI bD O mar behai C PRAM LORE BHETOTHS D O D C Dj PARAM IR A ce ASH HT HEBER AE do 2 1 paci Qs A 8 GDriW BO Guki QR RBE OME Oma ORR Ome WE oo fh 2 DAK
354. GIST imatnib imatinib 4 1 2010 118 2009 6 21 X 1 Hirota S Isozaki K Moriyama Y et al Gain of func tion mutations of c kit in human gastrointestinal stromal tumors Science 1998 279 577 580 PUR GHA ADAGE J rg ftl GISTA 2 fl Hy GE 2004 65 3307 3311 3 GIST GIST 2 2008 GIST 2007 96 460 466 2004 90 845 854 6
355. v XE EL UJIBSEREO d EAA 2 EH Z AT EBAGHNCS WPR MALL Tclostridium E O A8 WAAR HARBORS AHL DHENE WERS mO CRETE PREN H ERD DNI 7 RIEA WS HEAL A DAA pneumatosis intestinalis PI 20 portal venous gas PVG 21 PI PVG CT PI PVG PI PVG PL HEU PRE DINE SE DE L HOB AR SE
356. 0 9L 7 5 1 1L 62 1 10 1L 24 1 05L 6 1 10L 11 1 15L 6 1 2L 1 6T amp 1
357. BRS 4V V WV FIM 64 7 4 126 ADL OT BRS V IV
358. nies EMIS KO ATL bOBBAS A SH 19 20zg ST oe BRAE O A Ze 5 3 e SHAT Ze 8D g 75 EEO ii EN NAM sie ES od Ws T UO 7 5 1S EMIS k A ADRO IRAE D VO EHE EIE PCI on Bo Anl cioe DEO BECEO ZV ERAS primary PCI eI KO AT Y MAJ U EX KE LEO UE Bi 5p CABG HH xB
359. Diez Rit 70 ISHEESGE BE X 3 4 7 C1 2 8 10 3 OT 3 manual muscle test MMT 5 3 ADL LPU HRS A D AREE L oR ZAEB E RRIEO AEREI X 25 ROH SAH O5 OT ADL
360. 4 1 2010 1 2 A 80 ADL 3 3 21 12 22 1 4 1
361. 9 10 11 12 13 14 2008 4
362. MM 2007 4 1 2003 2003 10 2006 4 11 2007 1 3 4 Sha 9 10 2008 6 44 48 3 2 1 12 5 2 12 5 1
363. 1 2 2 161 Marchant THA TKA Marchant 68 58 6 79 5
364. 30 sae 4 idees D Ad Lain oes A
365. 1 CT 2 CT 152 170cm 67kg BMI 23 2 36 6 85bpm 134 93mmHg GCS11 E4VIM6 gt lt CT gt midline shift X gt ICU GCS 4 E1V1M 2 CT 3 4 2009 7 6 8 25
366. 2003 2003 2 2004 3 http www mhlw go jp toukei manual index html 22 internet accessed2010 3 25 164 Acute Abdomen 4 1 2010 Dir Bl pp NUR acute abdomen oncologic emergency iiUEzEJL 4 v A KIE 1200 Acute Abdomen
367. 38 2006 103 961 968 4 Terada T Nakanuma Y Pathological observations of intrahepatic peribiliary glands in 1000 consencutive autopsy livers Ill Survey of necroinflammation and cystic dilation Hepatology 1990 12 1229 1233 Aves Arak GEAR fe hepatic peribiliary cyst 1 H RIFE 2007 68 1775 1780 6 2009 7 5 YN 2006 60 1516 1522 4 1 2010 1 I IaVF ST 7 Me au Re aD ee i c son
368. stage 5 ELERE ro 7c BENT 8 EA EO TEES S D e FORDER BREE Ucolitie cancer amp Df amp Ti 3 29 28 Colitic Cancer 57 CT 20 CT S 29 71 CT 11 X 7 cm
369. 12900 7 CL 7900 0 13 4 1 2010 1b lb SHRED ME AE 1 0 SMEAR 2 0 c HERB RE AE 3 1 c HERB RE AE 4 1 c HERB RE AE 5 0 HERB RE AE 6 0 AB Sete Te 7 1 AB Sets SLUE 8 1 AB Se teenie 9 AME 11 fit xt 60 50 55 65 72 38 63 28 63 T HEE 1898 Wendel 2 1932 9 2 19824E 2 5 1999F X CO HABE 6 9
370. 147 C PC Stage IV 57 VEO T 152 156 159 ik 162 Acute Abdomen 165 180 182 183 187 188 4 1 2010 i FS 21 8 30 45 22 7 11 22 21 7
371. PaCO gt 35 7torr 4 5 IPV 13 IPV 2
372. 1 2010 DM DM DM PT KS BEER OO ERE EL IEDM HE PT DM PT DM PT
373. 1 HPFELE 1 BARRE 1 sup eee etx ees EN Lacs dunes TOME ee MF XY AER ER ndo EAM RU dA P TM MGS 3 3 Fv LR 1 A r6 Zu Bam ica Po Fit Fi2 Esc ORP RORE ANE PEAT MENR KMn MEEA BRNE SR MOS 4 4 IARE 4 1 10
374. 120 3 x 1 amp 2008 TAS 4 1 2010 4 1 2010 5S sus Hl 5S 5S 58S
375. 3 1 EER DAC SEES UE OO fre ii referred pain C ABUELA EDS HEU COEUR ECCO OO JL A 22 UR HS iii 2 II M i 1 Boerhaave 2 LAC KV SIEOWA FILE X RTH CH 40 50
376. 4 1 2010 8 5 10 7 16 3 3 Amat PAN P L 3 1
377. 5 2 Original article 8 000 1 400 5 300 ZAA 5 30 3 Case report 8 000 1 400 5 300 5 m 20 183 4 1 2010 4 Short report
378. 7 5 80 110 62 3 1 45L 10 30 2 10 10L 10 1 2 3 5 8L 70 8 100 100 100 100 1L 1 05 1 2L 10 A
379. blc a Rs ER A ER n ial Wl 2010 3 31 E or d M w SEED GR or es e TT Filter a 1 79 Ar ESSA 24 a WU UL CCU ene II 2009 4 1 2010 3 1 2 2 2 2 1 86 2 77
380. free air air window free air 5 CT CT 22 23 24 25 6 1 1 2 3 177 4 1 2010 1 5 7
381. 1 fill 76 aR aye PCI CABG 70 76 Fit Fit non contact mapping WIR PAC 152cm 50kg 34 144 86mmHg 1 1 PAC PAC NCM PAC PAC 2 1 74
382. 2003 4 2009 2008 2 6 21 2004 2 VN 5 Va 4 1 2010 2008 4 Dill XE A e ESSE TE EE OU BA A 2 7 7 BR FAT WO 9 BE 858 MO RES 8 GH 3 1 2 3 4 5 6 7 8
383. ADL 67 BRS G4 N V V Il FIM 28 6 3 OTC 1 FMI 4 1 2010 EH ADL 87
384. M2 2 X 1 8 2 ICU PaCOs 3 wheeze wheeze IPV 3 IPV 4 1 2010
385. Mi 1 HEME vo 6 Whirl Sisn CT 9 CT whirl sien MPR multiplanar reconstruction whirl sign 2 FRE 7 CT 3 ov T CAR
386. OJ 76 3 55 432 5 73 135 58 039 1 24 173 1 84544 5 73 26 m 0 20 2 40 60 80 MARIE BBE 3 60 80 100 139 4 1 2010 2 2 Ui
387. e e e e e BRE e 5 GIST e 3v e e 75 89 fil 142 27 8 6 144 101 76 68 56 289 165 4 1 2010 2 2009 235 e REX e e e e 62 2 46 10 24 0 18 3 13 3 kB 10 10 9 1 2 0 e 2 0 e 18 14 6 14
388. 18 PT 2 77 TO BER OV HF BARS AT ADL x PT 1 1 26 27 PT 1 3 10 38 PT 15
389. 1995 D 10 2005 135 4 1 2010 3
390. 2 CT c ESNIPS EDR AREE HURR k 2 PALE EHI S amp BE 7 3 2008 8 50 X35mm 2 6 ley D gt lt 104 Atk Gh bu Ag 4 1 2010 CK17 9 StS EEEE o ONSSCRESE TR 121 i5 N 4
391. 300 5 10 184 4 1 2010 8 Report and information 4 000 1 400 5 300 5 10 9 CPC CPC 2006
392. MS 10 5 BO E 1 2 1 2 3 181 4 1 2010
393. geometry CHS NCM 2 XX NCM g 1987 2 Non contact mapping NCM
394. 4 1 2010 2 3 2 6 34 33 43 HbA1c n 104 2 RO 27 19 FE 18 13 27 3 27 26 27 26 34 1396 9 18 17 19 18 n 104 3 60mg 17 4 4 i 4 2496 t BY 16 87 84 n 104 n 17 x 4 DM PT 1 1 1 A 2 2 A 2
395. 1 HbA1c 6 5 69 21 1997 0 4 2002 1 6 Ag ici ARE Ze DO BURA AS HO ZADIN 148
396. 2009 Wh 2008 http www j circ or jp guideline pdf JCS2009_andoh_h pdf Hl fe EFE VRB SPR LEE if 2008 2 1 6 15 Va 3 100 AP R 4 1 2010 U SCANNER II RNR GEA t um x UO USCANNER 50 25 Hl
397. 4 1 2010 3 FH BH ADL OT ADL OT pj ED ADL 3 ADL
398. 6 4 57 1 U 18 54 5 3 16 7 M 11 33 3 1 9 1 4 12 1 0 0 0 15 45 4 0 0 0 11 33 3 3 27 2 5 15 2 1 20 0 2 60 6 0 0 0 13 39 4 3 23 1 2 6 1 0 0 0 5 15 2 1 20 0 10 30 0 0 0 0 0 9 CASAS T BEATS BAGH 8 91 3 09 very low 5 15 2 0 0 0 low 14 42 4 0 0 0 intermediate 5 15 2 0 0 0 high 9 27 3 4 44 4 2 imatinib Bee En won 1 70 F F B 2005 4 2006 1 0 150mm imatinib PD IZE ZE Hy 2 70 F BRAR 2005 5 H 2005412A 110mm MBB REM UC PD imatinib 15 imatinib GIST 4 61 M 2008 4 330mm imatinib MRB CHET imatinib Er on EX GIST 5 42 M B
399. CD34 GIST 2 1998 1 2009 12 GIST 1 33 1 454 4 2 GIST 1 603 1 630 imatinib 41 85 64 6 4 71 6 56cm 4 10cm GIST 9 4 1 2010
400. D HH L A BH BL CH CL DH DL D CL 80 1 1 2 3 Microsoft Ex cel
401. H20 6 H21 79 H20 6 H21 79 4 15 2 BI 45 16 841 471 941 494 580 293 20 54 1 36 3 52 42 6 23 2 2007 4 2008 5 2008 6 2009 9
402. Ogura M Morishima Y Kobayashi Y et al Du Va rable response but prolonged cytopenia after cladribine treatment in relapsed patients with in dolent non Hodgkin s lymphomas results of a Japanese phase II study Int J Hematol 2004 80 267 277 4 1 2010 2 2 1 2 1 4 13 2006 2008 2009 2 fill 3 6 2
403. cell rich neointima through 5 hydroxytryptamine2A receptor in rabbit femoral arteries Journal of Thrombosis and Hemostasis 2009 20 4 422 427 Pristipino C Beltrame JF Finocchiaro ML Hattori R Fujita M Mongiardo R Cianflone D Sanna T Sasayama S Maseri A Major racial dif 4 WV ferences in coronary constrictor response be tween Japanese and Caucasians with recent myo cardial infarction Circulation 2000 101 1102 1108 Moukarbel GV Dakik HA Diffuse coronary ar tery spasm induced by guidewire insertion J Invas cardiol 2003 15 353 354 6 Yoshida T Kobayashi Y Nakayama T Kuroda Va 5 4 1 2010 7 8 9 Va VN N Komiyama N Komuro I Stent deformity caused by coronary artery spasm Circ J 2006 70 800 801 Corcos T David PR Bourassa MG Val PG Rob ert J Mata LA Waters DD Percutaneous transluminal coronary angioplasty for the treat ment of variant angina J Am Coll Cardiol 1985 5 1046 1054 Bertrand ME LaBlanche JM Thieuleux FA Fourrier JL Traisnel G Asseman P Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis J Am Coll Cardiol 1986 8 504 508 Sakai Y Fujiwara S Tomobuchi Y De novo coro nary spasm mimicking acute thrombosis after coronary stenting J Wakayama Med 2005 56 4 224 228
404. g dl ALT 30IU L AMY 60IU L ALP 326IU L CRP 13 68 mg dl 4 1 2010 5 mm 1 2 cm 1 20i N6 f 1 CT 3 ERCF 2 2 M CT MRCP hepatic peribiliary cysts 4 5 a a ee 4 CT 2 CT EST NBD 3 5 MRCP ERCP
405. gastrointestinal stromal tumour after fail ure of imatinib a randomized controlled trial Lancet 2006 368 1329 1338 Raut CP Posner M Desai J Morgan JA Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors J Clin Oncol 2004 24 15 2325 2331 Eisenberg BL Harris J Blanke CD et al Phase II trial of neoadjuvant adjuvant imatinib mesylate IM for advanced primary and metastatic recur rent operable gastrointestinal stromal tumor GIST early results of RTOG0132 ACRIN 6665 J Surg Oncol 2009 99 1 42 47 4 1 2010 hepatic peribiliary cysts 1 TU OB ROR 8 iA dug mk FREST GH BA WH 73 1 3 50 2009 12 CT 1 2 cm
406. 1 4 1 2010 1 1
407. 2 2008 6 R 2007 4 2009 9 91 66 25 57 1 14 3 46 1 15 4 3 5 4 1 2010 Fs ab eS 2 3 gt WEZ H19 4 H20 5 H20 6 H21 9 16 39 41 0 18 28 64 2 10 24 41 6 28 52 53 8 0 H19 4 H20 5
408. 34 113 118 Khurana B The Whirl Sign Radiology 2003 226 69 70 14 CT 2 hh Jv 2009 1 306 Cherian PT and Parnell AP The diagnosis and clas sification of inguinal and femoral hernia on multisection spiral CT Clin Radiol 2008 63 184 192 85 20 2007 27 435 440 Ikematsu Y YamanouchiK Nishiwaki Y et al Gallbladder volvulus experience of six consecu tive cases at an institute J Hepatobiliary Pancreat Surg 2000 7 606 609 BHBET VIO GSPEA f itet CT 2009 54 1643 1648 OD 50 2009 48 50 MAGA HHBAOBR AT F24 7 1 179 Wa 4 1 2010 2005 152 153 21 ss
409. 39 te ll b a 16 3 2 PC 4 EHE 93 3 NH ETHO I7 75 3 1 2 5S 97 1 3 5S 6 89 2 9 95 1 1
410. 4L lt 4 90 4 5L L 0 13 X 1 Medical Gases 2000 2 1 43 45 R 44 1 2010 Bl 2007 4
411. 80 130 650mA modulation40 80 100 M3 SD Modu ation 100bpm 60 modulation 4 a 7 m 0bpm 45 150bpm 30 F A 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 Recon 3 100 120 150 IBL 43 D130 650mA modulation40 60 2 2 Modulation 4 5 6 113 4 1 2010 4 120kV 130 650mA modulation75 25 a 10 60 80 HR 5 60 80 130 650mA modulation40 80 6 100 120 150
412. 90 6 ECMO Vol29 829 834 7 D GM CSF 67 269 274 4 1 2010 8 ME Wylam et al Aerosol granulocyte macroph age colony stimulating factor for pulmonary alveo lar proteinosis Eur Respir J 2006 585 593 9 F C Lin et al Clinical significance of ant GM CSF antibodies in idiopathic pulmonary alveolar proteinosis Thrax 2006 61 528 534 10 GM CSF 1 47 2009 833 838 4 1 2010 3 2 IRF tE BA pi AB AA RAO
413. B SER I 2009 12 220mm 1 751 A imatinib GIST GIST GIST retrospec tive study 3 Phase RTOG0132 imatinib600mg imatinib 4 12 400mg 2 FDG PET 2
414. DM DM PT PT PT PT 20 1 PT 500 270 230 71 18 w PODMPRERIEH10440 5 5HbA1cO fii 23 3 5 76 1 76 1 HbAlc HbAlc HbAlc DM lt 5 8 5 8 6 4 uf 6 5 7 9 8 0 HbA1c 8 18 33 17 HbAlc PE 6 3 3 129
415. Howship Romberg 19 994802 AES fr 4 1 2010 8 KMAL rH 91 CT CT 15 9 88 CT CT free air 4 Ss
416. ISSN 1882 6474 4 1 22 The Journal of Hamamatsu Medical Center Vol 4 No 1 2010 OR The Journal of Hamamatsu Medical Center Vol 4 No 1 2010 4 1 2010 4 22 2 22 H 28 Stephen Schultz 6 CRAB AF 10 16 1 22 1 9 25 2 CdA RCHOP Bee Ai 30 2 34 1 38 Non Contact Mapping
417. MV 173 4 1 2010 2004 09 17 16 49 41 21 60 CT 2 cm benign form iv 1 22 interventional radiology IR IR
418. Professor of Family Medicine 2010 2 2 1
419. artmann 4 1 2010 DENS PMX PMX 7 iatrogenic perforation of colon
420. bil 1 34 mg dl Ht 47 7 ALT 25 IU I i i B PIt 19 2 10 4 yl AST 22 IU AHA LDH 199 IU I MURIS mu PT INR 1 15 ALP 306 IU I APTT 99 3sec CK 68 IU I as BUN 11 7 mg dl 20 30 X207k H RF 2 U I Cre 1 26 mg dl 40 UA 9 6 mg dl Na 140 mEq l Z 2A gt D 5pg ml K 3 9 mEq l 17 BET CI 101 mEq Y Web gt Edi CEA 4 4ng ml Ca 8 4 mg dl 19 2 5 mg dl 2 4 VC 3 44L e cu e VC 97 CRP 2 51 mg dl FEV1 0 2 9L pee a ee E FEV1 0 86 196 SP D 273 IU I 22 2 DL 61 8 4 1 2010 1 CT 2 1
421. ides FAT 0 5 1 2 mO AIRS SRAM 5 ES E X ST
422. ke EL Ai T 2 7 2 2 3 1 amp 2006 2005 6 palliative care team PCT 4 PCT PCT PCT
423. mHg 10ml h 1 50cc PASE RR HEE 300 600mmHg 800mmHg 4 10ml 396 4 J BHSERRIMEEO JUEZ C 800mmHg 300 600mmHg iff 5 6
424. omputed tomography CT CT CT CT 60 RR 75 HghtSpeed VCT
425. the gallblad der Arch Surg 1936 32 131 162 W HHSEOJERE 1968 18 367 369 Carter R Thompson RJ Brennan LP et al Vol vulus of the gallbladder Surg Gynecol Obstet 1963 16 105 108 SacBee PA sedi oh zc etr UL 7 HA Sede ihe 011 2008 69 886 890 4 1 2010 2 CdA 23 LACE ET ME 235 HEL Ze R CHOP 2 9 ALA AGES Je 63 200X XX 4 R CHOP 2 CdA
426. uma death ofEthe job training JPTEC Japan prehospital trauma evaluation and care JATECTM Japan advanced trauma evaluation and care JNTEC Japan nursing for trauma evalua tionand care
Download Pdf Manuals
Related Search